Please use this identifier to cite or link to this item:
|Title:||Apoptosis and angiotensin II: yet another renal regulatory system?||Austin Authors:||Bonnet, Fabrice;Cao, Zemin;Cooper, Mark E||Affiliation:||Department of Medicine, University of Melbourne, Austin and Repatriation Medical Centre, Heidelberg West, Victoria, Australia||Issue Date:||2001||Publication information:||Experimental Nephrology; 9(5): 295-300||Abstract:||Apoptosis plays a key role in the regulation of normal renal structure and kidney remodeling in various renal diseases. Angiotensin II plays a prominent role in renal injury through its receptor subtypes, the type 1 (AT1) receptor and the type 2 (AT2) receptor, which involve different molecular mechanisms. In addition to its haemodynamic actions, angiotensin II induces apoptosis. Angiotensin II also increases proliferation in the kidney. A close correlation between renal cell proliferation and apoptosis has been shown in renal diseases as well as in the angiotensin II infusion model. Angiotensin induces upregulation of p53 and other pro-apoptotic proteins. Recent studies suggest that both AT1 and AT2 receptors influence the apoptotic process in the kidney. These apoptotic effects of angiotensin II should be considered as representing another regulatory mechanism that may modulate the balance between cell growth and proliferation within the kidney.||Gov't Doc #:||11549846||URI:||http://ahro.austin.org.au/austinjspui/handle/1/9339||DOI:||52624||URL:||https://pubmed.ncbi.nlm.nih.gov/11549846||Type:||Journal Article||Subjects:||Angiotensin II.metabolism
Tumor Suppressor Protein p53.metabolism
|Appears in Collections:||Journal articles|
Show full item record
checked on Dec 5, 2022
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.